Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis

• Published in: Journal of clinical medicine 2023-07, Vol.12 (14), p.4656
• Main Authors: Katsarogiannis, Evangelos, Landtblom, Anne-Marie, Kristoffersson, Anna, Wikström, Johan, Semnic, Robert, Berntsson, Shala G
• Format: Article
• Language: English
• Subjects: Biomarkers; Cerebrospinal fluid; Clinical medicine; Diagnostic imaging; Diagnostic tests; differential diagnosis; Disease; Immunoglobulin G; Immunology; Investigations; Magnetic resonance imaging; Medical records; Medical research; Medicine, Experimental; Multiple sclerosis; oligoclonal bands; Spinal cord; Statistical analysis
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12144656

Immunoglobulin gamma (IgG) oligoclonal bands (OCB) in the cerebrospinal fluid (CSF) are absent in a small group of multiple sclerosis (MS) patients. According to previous research, OCB-negative MS patients differ genetically but not clinically from OCB-positive MS patients. However, whether OCB-negative MS is a unique immunological and clinical entity remains unclear. The absence of OCB poses a significant challenge in diagnosing MS. (1) Objective: The objective of this study was twofold: (1) to determine the prevalence of OCB-negative MS patients in the Uppsala region, and (2) to assess the frequency of misdiagnosis in this patient group. (2) Methods: We conducted a retrospective study using data from the Swedish MS registry (SMSreg) covering 83% of prevalent MS cases up to 20 June 2020 to identify all MS patients in the Uppsala region. Subsequently, we collected relevant information from the medical records of all OCB-negative MS cases, including age of onset, gender, presenting symptoms, MRI features, phenotype, Expanded Disability Status Scale (EDSS) scores, and disease-modifying therapies (DMTs). (3) Results: Out of 759 MS patients identified, 69 had an OCB-negative MS diagnosis. Upon re-evaluation, 46 patients had a typical history and MRI findings of MS, while 23 had unusual clinical and/or radiologic features. An alternative diagnosis was established for the latter group, confirming the incorrectness of the initial MS diagnosis. The average EDSS score was 2.0 points higher in the MS group than in the non-MS group ( = 0.001). The overall misdiagnosis rate in the cohort was 33%, with 22% of misdiagnosed patients having received DMTs. (4) Conclusions: Our results confirm that the absence of OCB in the CSF should raise suspicion of possible misdiagnosis in MS patients and prompt a diagnostic reassessment.